Some stock data isn't available right now.
Viatris Inc. Common Stock (VTRS)
Underlying price
$19.62+3.45% today
Stock stats
- Market cap
- $22.8B
- Previous close
- $18.97
- Open
- $18.79
- Day's range
- $18.78 – $19.92
- 52-week range
- $9.92 – $19.96
- Volume
- 12.0M
- Avg volume
- 8.83M
- P/E ratio
- -
- EPS
- -$0.53
- Dividend yield
- 2.44%
- Beta
- 0.847
- Next earnings
- -
About Viatris Inc. Common Stock
Viatris was formed in November 2020 through the combination of Upjohn, a wholly owned subsidiary of Pfizer that specialized in off-patent drugs, and Mylan, a global pharmaceutical manufacturer that focused on generic and specialty drugs. By joining forces, Viatris became one of the largest generic drug manufacturers in the world, servicing over 165 countries. Generics (commoditized and complex) and biosimilars make up one-third of Viatris' total sales. The remaining sales are derived from its portfolio of legacy products, including Lipitor, Norvasc, Lyrica, and Viagra.
- Ticker
- VTRS
- Asset class
- Equity
- Tokenized by
- 0 issuers
- Sector
- Healthcare
- Industry
- Pharmaceutical Preparations
- Employees
- 30,000
- Website
- viatris.com